Literature DB >> 6788972

Development of fat emulsions.

A Wretlind.   

Abstract

The studies on the possibility of preparing IV fat emulsions began in the 1920's; since then, a very large number of emulsions with various fats and emulsifiers have been investigated. However, none of the early fat emulsions could be used safely in man. By the trial and error technique, a method was finally found to prepare soybean oil and egg yolk phospholipids to make a fat emulsion that had a low incidence of adverse reactions. A newly devised biological test system based on nutritional concepts was of crucial importance. It meant that any energy supplying nutrient should be tested in animals in relation to the energy requirement of the species used and not identical to the human dose/kg body weight as in the "classical" toxicity and tolerance tests. With the development of well-tolerated IV fat emulsions it has been possible to devise a TPN regimen that is adequate from a nutritional point of view as well as an adequate alternative to the ordinary oral food. This regimen, which can be administered by the peripheral route, means that the original aims for developing IV fat emulsions were finally achieved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788972     DOI: 10.1177/0148607181005003230

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  12 in total

Review 1.  Injectable lipid emulsions-advancements, opportunities and challenges.

Authors:  Ketan Hippalgaonkar; Soumyajit Majumdar; Viral Kansara
Journal:  AAPS PharmSciTech       Date:  2010-10-26       Impact factor: 3.246

Review 2.  The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications.

Authors:  K Iriyama
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 3.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

Review 4.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

5.  Cholesterol improves the utilization of parenteral lipid emulsions.

Authors:  Wilfred Druml; Margot Fischer
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

6.  Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients.

Authors:  Vincent E de Meijer; Hau D Le; Jonathan A Meisel; Kathleen M Gura; Mark Puder
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

7.  Olive Oil and Soybean Oil Based Intravenous Lipid Emulsions, Liver Biochemistry and Clinical Outcomes.

Authors:  Fabio Araujo; Tanis R Fenton; Sara Lukmanji; Maitreyi Raman
Journal:  Nutrients       Date:  2018-05-23       Impact factor: 5.717

8.  Parenteral nutrition-induced cholestasis in neonates: where does the problem lie?

Authors:  Kheira Jolin-Dahel; Emanuela Ferretti; Carolina Montiveros; Renee Grenon; Nick Barrowman; Carolina Jimenez-Rivera
Journal:  Gastroenterol Res Pract       Date:  2013-11-14       Impact factor: 2.260

Review 9.  Liver disease secondary to intestinal failure.

Authors:  Bassam Abu-Wasel; Michele Molinari
Journal:  Biomed Res Int       Date:  2014-01-15       Impact factor: 3.411

10.  Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.

Authors:  Cornelia M Keck; Mirko Jansch; Rainer H Müller
Journal:  Pharmaceutics       Date:  2012-12-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.